Related Experiment Video
Updated: Jul 4, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]
Insights
The neurotrophic peptide selank modulates immune responses by affecting interleukin-6 (IL-6) and Th1/Th2 cytokine balance. These findings suggest selank
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Interleukin-6 (IL-6) plays a critical role in immune responses and is implicated in various disorders.
- Cytokine balance, particularly the Th1/Th2 axis, is crucial for immune homeostasis.
- Selank, a novel neurotrophic heptapeptide, warrants investigation for its immunomodulatory potential.
Purpose of the Study:
- To investigate the immunotropic effects of the neurotrophic heptapeptide selank.
- To assess selank's impact on interleukin-6 (IL-6) gene expression and concentration.
- To examine selank's influence on the Th1/Th2 cytokine balance in vivo.
Main Methods:
- In vitro experiments assessed IL-6 gene expression and concentration in peripheral blood cells.
- Peripheral blood cell cultures from patients with depression and healthy controls were used.
- In vivo studies analyzed Th1/Th2 cytokine balance in patients with anxiety-asthenic disorders receiving selank.
Main Results:
- Selank (10-7 M) suppressed IL-6 gene expression in patients with depression but not healthy controls.
- A significant increase in IL-6 concentration was observed in patient cell cultures with selank.
- Selank administration altered Th1/Th2 cytokine balance in patients with generalized anxiety disorder and neurasthenia.
Conclusions:
- Selank exhibits immunomodulatory effects, impacting IL-6 and cytokine balance.
- These findings support selank's potential as a novel immunomodulator for anxiety-asthenic disorders.
- Selank's adaptogenic properties may aid in preventing infectious diseases in vulnerable populations.
Abstract:
The purpose of this article was to study the immunotropic effects of the new neurotrophic heptapeptide selank. The experiments in vitro revealed that the drug in concentration 10-7 M completely suppressed gene expression by peripheral blood IL-6 of patients with depression but not of the healthy controls. At the same time, the significant increase (p<0,05) of IL-6 concentration was observed in the cell culture of peripheral blood of patients in the presence of selank. The changes of the Th1/Th2 cytokine balance in vivo were found in the serum of patients with generalized anxiety disorder and neurasthenia who received Selank during 14 days. The dynamics of these changes had the significant inverse correlation dependence. The cytokine regulating effects revealed in the study suggest that selank can be used as a novel immunomodulator in patients with anxiety-asthenic disorders. Additionally, the adaptogenic properties of selank may be beneficial to its use in elderly people and people exposed to environmental stressors for the prevention of infectious diseases.
Related Concept Videos
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Generalized Anxiety Disorder
Psychoneuroimmunology: Diabetes and Cancer
